Evidence map›Paper›PMID 34046500›Full record

ArticleBioMed research international2021

Noyes-Whitney Dissolution Model-Based pH-Sensitive Slow Release of Paclitaxel (Taxol) from Human Hair-Derived Keratin Microparticle Carriers.

V W Wimalasiri, S P Dunuweera, A N Dunuweera, R M G Rajapakse

Open access · hybridAbstract read
In one paragraph

Article in BioMed research international, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
1.3field-weighted citation impact, top 22% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 15 citations in OpenAlex.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

V W WimalasiriDepartment of Chemistry, Faculty of Science, University of Peradeniya, Sri Lanka.ORCID https://orcid.org/0000-0001-9466-6695
S P DunuweeraDepartment of Chemistry, Faculty of Science, University of Peradeniya, Sri Lanka.ORCID https://orcid.org/0000-0003-0197-423X
A N DunuweeraDepartment of Basic Science, Faculty of Allied Health Sciences, University of Peradeniya, Peradeniya 20400, Sri Lanka.ORCID https://orcid.org/0000-0002-6564-7337
R M G RajapakseDepartment of Chemistry, Faculty of Science, University of Peradeniya, Sri Lanka.ORCID https://orcid.org/0000-0003-3943-5362
University of Peradeniya · LK

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

This paper describes a convenient and straightforward method developed to extract keratin particles (KPs) from human hair. It also involves their characterization by several methods and encapsulation of the anticancer drug Paclitaxel (Taxol) within them, aiming for targeted delivery to cancerous sites and slow release at their vicinity. The KPs obtained were in micrometer in size. They are capable of encapsulating Taxol within them with a high encapsulation efficiency of 56% and a drug loading capacity of 2.360 g of Taxol per g keratin. As revealed by the SEM elemental analysis, KPs do not contain any toxic metal ion, and hence, they pose no toxicity to human cells. The pH-dependent release kinetics of the drug from KPs indicates that the drug is released faster when the pH of the solution is increased in the 5.0 to 7.0 pH range. The release kinetics obtained is impressive, and once targeted to the cancerous sites, using cancer directing agents, such as folic acid; a glutamate urea ligand known as DUPA; aminopeptidase N, also known as CD13; and FAP-

Indexed as

Antineoplastic AgentsAntineoplastic Agents, PhytogenicDrug CarriersDrug Delivery SystemsDrug LiberationFolic AcidHairHumansHydrogen-Ion ConcentrationKeratinsPaclitaxelParticle SizeSolubilityAntineoplastic AgentsAntineoplastic Agents, PhytogenicDrug CarriersFolic AcidKeratinsPaclitaxel

Identifiers

PMID34046500
PMCPMC8128610
OpenAlexW3161165605

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.